Orforglipron
Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
Eli Lilly · Phase 4 · Not yet recruiting · Enrollment 60
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.